ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Strensiq 100 mg/ml, Injektionslösung - 12
66086020 PPAlexion Pharma GmbH
Strensiq 100 mg/ml, Injektionslösung16.08.2016
  16.08.2016
Asfotase Alfa (A16AB13) 
WHO-DDD 
12
07.14. 
A  
No 
IPCI
PR  
k.A.PR
  
7680660860201Biotechnologika
  
Composition
asfotasum alfa 100 mg, natrii chloridum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution
 
 
Active AgentDose
Asfotasum Alfa100 mg/ml
 
Inactive agents
Disodium Phosphate Heptahydrate
Sodium Chloride
Sodium Dihydrogenophosphate Monohydrate
Source
Data was imported : 05.01.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home